Evidence supporting the use of: Transforming growth factor
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Transforming growth factor-beta (TGF-β) is a cytokine known to play a complex role in bone remodeling. Preclinical studies have shown that TGF-β regulates the activity of both osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells), suggesting a potential impact on bone density and structure. Some animal studies indicate that modulating TGF-β signaling can influence bone mass and may slow bone loss, which is relevant to osteoporosis. However, TGF-β's effects are highly context-dependent; for example, excessive TGF-β signaling is associated with bone fragility and increased risk of fractures in some models.

As of 2024, there is no approved clinical therapy involving direct administration of TGF-β for osteoporosis in humans. Most human research has focused on understanding TGF-β's role in bone biology rather than developing it as a drug. Some experimental drugs target the TGF-β pathway to modulate bone turnover, but these remain largely in early-stage development or preclinical testing.

In summary, while there is a scientific rationale and preclinical evidence suggesting that TGF-β plays a role in osteoporosis pathophysiology, there is currently limited direct clinical evidence supporting its use as a treatment. Thus, the evidence level is rated as 2, reflecting promising mechanistic and animal data but a lack of clear, validated human trials or approved therapies.

More about Transforming growth factor
More about Osteoporosis

Products containing Transforming growth factor

We currently have no products on Vitabase that contain this ingredient.